BSG Series CM, LLC 13D and 13G filings for Coeptis Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 09:09 am Sale | 2026-04-30 | 13D | COEPTIS THERAPEUTICS HLDGS INC COEP | BSG Series CM, LLC | 0 0.000% | -41,521,276 (Position Closed) | Filing |
| 2026-05-04 8:07 pm Purchase | 2026-04-24 | 13D | COEPTIS THERAPEUTICS HLDGS INC COEP | BSG Series CM, LLC | 41,521,276 80.730% | 41,521,276 (New Position) | Filing |